45 participants
R-MTX-zanbrutinib in Secondary CNS Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-05-31
- Start Date:
- 2021-02-26
- Completion:
- 2024-02-26
Conditions
- Secondary Central Nervous System Lymphoma
Interventions
- DRUG
No Results Yet